Company

Nested Therapeutics, Inc.

Nested Therapeutics develops precision medicines for cancer using computational and biological research methods.

About

Nested Therapeutics uses genomics, computational biophysics, machine learning and chemical biology to discover precision medicines for cancers and tumors. Founded in 2021 by Klaus Hoeflich, Kevan Shokat and Arvin Dar, it is based in Massachusetts, US. In April 2022, it raised USD 50 million in Series A funding led by Goldman Sachs Asset Management, with participation from Avidity Partners, Cowen Investment Management, Foresite Capital, Versant Ventures and Section 32.

2Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in